flow trial semaglutide kidney 2024 FLOWing with the — NephJC Patients with type 2 #diabetes

SKU: 335093107

Pay in 4 interest-free payments of $5.05 Learn more

Live Spec

Patients with type 2 #diabetes and chronic kidney disease are at high risk for kidney failure, cardiovascular events, and death. Whether treatment with semaglutide would mitigate these risks is unknown. FLOW Trial Shows Benefit of Semaglutide in Type 2 Diabetes and Chronic Kidney Disease: EASD 2024 EMJ Semaglutide in patients with overweight or obesity and chronic kidney disease without diabetes: a randomized double blind placebo controlled clinical trial Nature Medicine Cardio kidney metabolic protective effects of semaglutide across the spectrum of chronic kidney disease

Store: buntepalette-gmbh.de · Domain: buntepalette-gmbh.de